|
⚲
|
| Keyboard |
| Lawrence Miller | |
|---|---|
| Firm | |
| Address | 39 John F Kennedy Street, 4th Fl Cambridge, MA 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Apnimed Inc | 021-578027 | Executive Officer | 25.0 M of 25.0 M |
||
| Apnimed Inc | 021-558476 | Executive Officer | 35.0 M of 35.0 M |
||
| Apnimed Inc | 021-544389 | Executive Officer | 16.5 M of 16.5 M |
||
| Apnimed Inc | 021-496807 | Executive Officer | of 37.5 M |
||
| Holganix LLC | 021-475139 | Director | 2.4 M of 2.5 M |
||
| Apnimed Inc | 021-468579 | Executive Officer | 79.7 M of 79.7 M |
||
| Apnimed Inc | 021-445175 | Executive Officer | 62.5 M of 62.5 M |
||
| Apnimed Inc | 021-393539 | Executive Officer | 25.0 M of 25.0 M |
||
| Apnimed Inc | 021-364430 | Executive Officer | 15.0 M of 15.0 M |
||
| Apnimed Inc | 021-316175 | Executive Officer | 25.6 M of 25.6 M |
||
| Sequella Inc | 021-296216 | Executive Officer | 0.6 M of 3.6 M |
||
| Holganix LLC | 021-283778 | Director | 0.1 M of 3.0 M |
||
| Sequella Inc | 021-271120 | Executive Officer | 0.9 M of 0.9 M |
||
| Sequella Inc | 021-271119 | Executive Officer | 1.7 M of 3.0 M |
||
| Customink LLC | 021-237595 | Director | 1.1 M of 1.6 M |
||
| Macrolide Pharmaceuticals Inc | 021-234735 | Executive Officer | 12.2 M of 27.8 M |
||
| Holganix LLC | 021-229050 | Director | 0.3 M of 5.4 M |
||
| Sequella Inc | 021-226211 | Executive Officer | 3.1 M of 3.1 M |
||
| Customink LLC | 021-206530 | Director | 40.0 M of 40.0 M |
||
| Sequella Inc | 021-203833 | Executive Officer | 0.6 M of 2.4 M |
||
| Holganix LLC | 021-192652 | Director | 1.0 M of 2.0 M |
||
| Activate Networks Inc | 021-186929 | Executive Officer | 10.0 M of 10.0 M |
||
| Independence Bancshares Inc | 021-184578 | Executive Officer | of 15.0 M |
||
| Sequella Inc | 021-183572 | Executive Officer | 0.1 M of 3.0 M |
||
| Pangenx Inc | 021-181341 | Executive Officer | 0.9 M of 10.1 M |
||
| Activate Networks Inc | 021-177372 | Executive Officer | 1.0 M of 1.0 M |
||
| Mediphase Venture Partners Annex Fund LP | 021-174010 | Executive Officer | 0.3 M of 0.5 M |
||
| Sequella Inc | 021-168236 | Executive Officer | 0.1 M of 3.0 M |
||
| Sequella Inc | 021-164202 | Executive Officer | 0.6 M of 4.0 M |
||
| Sequella Inc | 021-160651 | Executive Officer | 1.0 M of 1.5 M |
||
| Mednetworks Inc | 021-146143 | Executive Officer | 1.8 M of 5.0 M |
||
| Stonemor Partners LP | 021-144196 | Executive Officer | 12.9 M of 13.4 M |
||
| Tetraphase Pharmaceuticals Inc | 021-142724 | Director | 44.8 M of 45.0 M |
||
| Mediphase Venture Partners II Select Fund Limited Partnership | 021-141020 | Promoter | 1.8 M of 2.0 M |
||
| Danforth Pewterers Ltd | 021-94163 | Executive Officer | 0.4 M of 0.6 M |
||
| Tetraphase Pharmaceuticals Inc | 021-94056 | Director | 10.0 M of 29.6 M |
||
| Sequella Inc | 021-77512 | Executive Officer | 2.0 M of 6.0 M |
||